CSF1R inhibitors have been shown to suppress cancers. We have attempted an in silico fragment derived drug discovery approach by screening ˜25,000 in-house ...

In the present study fragment-based drug discovery (FBDD) is applied to identify novel antagonists of CSF1R. FBDD draws strength from structural biology, ...

CSF1R inhibitors have been shown to suppress cancers. We have attempted an in silico fragment derived drug discovery approach by screening ˜25,000 in-house ...

Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design. Machiraju, Pavan Kumar; Yedla, Poornachandra; Gubbala, ...

CSF1R inhibitors have been shown to suppress cancers. We have attempted an in silico fragment derived drug discovery approach by screening ˜25,000 in-house ...

The identification of mechanistically novel drug targets is highly challenging, particularly for diseases of the central nervous system.

Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design ... Authors: Pavan Kumar Machiraju; Poornachandra Yedla; Satya ...

Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design. Published in. Computational Biology & Chemistry, May 2019. DOI ...

CSF1R inhibitors have been shown to suppress cancers. We have attempted an in silico fragment derived drug discovery approach by screening ˜25,000 in-house ...

Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design. Comput Biol Chem 2019;80:374–83. [PubMed] [Google Scholar].